Mithra Pharmaceuticals (MITPF) News Today $6.75 0.00 (0.00%) As of 05/29/2025 Add Compare Share Share Headlines Stock AnalysisChartBuy This Stock MITPF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Young Mithra’s amazing 62km cycle ride around the Rugby area raises funds for important causesJuly 8, 2025 | msn.comFirst Look of Priyadarshi-starrer Mithra Mandali unveiledJune 7, 2025 | msn.comThere are long and short opportunities in tech-focused funds, says Citi's Mithra WarrierNovember 22, 2024 | msn.comVolatility brings tactical opportunities, says Citi's Mithra WarrierSeptember 16, 2024 | msn.comComic roles no longer resonate with me: MithraAugust 18, 2024 | msn.comMithra postpones its annual general meetingMay 28, 2024 | finance.yahoo.comMithra enters into exclusive negotiations with Gedeon Richter and secures continued funding in the context of its monetization processMay 3, 2024 | finance.yahoo.comMithra updates on offers received in the context of its monetization process and on its Annual Report 2023April 29, 2024 | finance.yahoo.comMithra secures court protection measures to advance monetization processApril 22, 2024 | finance.yahoo.comMithra Pharmaceuticals SA MITRAbApril 16, 2024 | morningstar.comMMithra reports full year 2023 financial resultsMarch 8, 2024 | finance.yahoo.comMithra Pharmaceuticals: Mithra announces changes to its executive managementMarch 5, 2024 | finanznachrichten.deMithra Pharmaceuticals: Mithra initiates monetization process, receives bridge loan from existing lendersMarch 5, 2024 | finanznachrichten.deMithra announces changes to its executive managementMarch 5, 2024 | finance.yahoo.comMithra initiates monetization process, receives bridge loan from existing lendersMarch 5, 2024 | finance.yahoo.comMithra announces changes to its executive managementMarch 5, 2024 | finance.yahoo.comDONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phaseFebruary 29, 2024 | finance.yahoo.comMithra Pharmaceuticals: Mithra updates on cash positionFebruary 6, 2024 | finanznachrichten.deMithra updates on cash positionFebruary 6, 2024 | finance.yahoo.comMithra Pharmaceuticals S.A.January 19, 2024 | barrons.comMithra Pharmaceuticals SA MITRAJanuary 17, 2024 | morningstar.comMMithra and Rafa Laboratories sign binding Head of Terms to commercialize DONESTA® in IsraelDecember 21, 2023 | finance.yahoo.comMithra Pharmaceuticals: Mithra Completes Pediatric Study of ESTELLE® in Adolescent PatientsDecember 20, 2023 | finanznachrichten.deMithra Completes Pediatric Study of ESTELLE® in Adolescent PatientsDecember 20, 2023 | finance.yahoo.comMithra Reports Positive Review From DSMB On European Phase 3 Program For DONESTADecember 18, 2023 | markets.businessinsider.comMithra Receives Positive DSMB Opinion on DONESTA® European Phase 3 TrialDecember 18, 2023 | finance.yahoo.comMithra: Gedeon Richter To Have Commercial Rights For ESTELLE, DONESTA In ChinaDecember 4, 2023 | markets.businessinsider.comMithra and Gedeon Richter sign binding Head of Terms to commercialize ESTELLE® and DONESTA® in ChinaDecember 4, 2023 | finance.yahoo.comMithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United StatesNovember 30, 2023 | finance.yahoo.comMithra to hold five presentations on key role of estrogens in women’s health, including Estetrol (E4), at the ESG Congress in AmsterdamNovember 28, 2023 | finance.yahoo.comMithra’s NEXTSTELLIS® granted additional patent in the United StatesNovember 7, 2023 | finance.yahoo.comMithra releases invitation to its extraordinary securities holders’ meetingNovember 6, 2023 | finance.yahoo.comMithra to receive EUR 2.5 million milestone payment from Fuji Pharma under ESTELLE® licensing agreementOctober 23, 2023 | finance.yahoo.comMithra’s Board of Directors to propose the removal of its request for change of the remuneration policy at the Special General MeetingOctober 17, 2023 | finance.yahoo.comShareholder Revolt Looms at Mithra as Board Members’ Mandates ChallengedOctober 12, 2023 | msn.comMithra to Hold Presentations on Key Role of Estrogens in Women’s Health, Including Estetrol (E4), at FIGO World CongressOctober 10, 2023 | finance.yahoo.comMithra Provides an Update in the Context of Recent Market DevelopmentsOctober 5, 2023 | finance.yahoo.comJagan Mohan Reddy to release Vahana Mithra aid todaySeptember 28, 2023 | msn.comMithra Announces Presentation of Positive Data on Estetrol (E4) Native Estrogen at NAMS 2023September 27, 2023 | finance.yahoo.comMithra Financial Results for First-Half 2023September 26, 2023 | finance.yahoo.comMithra to Hold Investor Call on H1 2023 Financial Results on September 26 at 14:00 CESTSeptember 21, 2023 | finance.yahoo.comInformation on the total number of voting rights (denominator)September 21, 2023 | finance.yahoo.comMithra Pharmaceuticals SA (MITPF)September 16, 2023 | finance.yahoo.comMithra Pharmaceuticals: Publication of a Transparency Notification Received from Armistice Capital, LLCSeptember 12, 2023 | finanznachrichten.dePublication of a Transparency Notification Received from Armistice Capital, LLCSeptember 12, 2023 | finance.yahoo.comMithra Pharmaceuticals: Letter to Shareholders and Corporate UpdateSeptember 11, 2023 | finanznachrichten.deDEGROOF PETERCAM Maintains Mithra Pharmaceuticals (EBR:MITRA) Buy RecommendationAugust 31, 2023 | nasdaq.comKBC SECURITIES Downgrades Mithra Pharmaceuticals (EBR:MITRA)August 31, 2023 | nasdaq.comMithra completes EUR 20 million private placement in equity Update of total number of voting rights (denominator)August 28, 2023 | finance.yahoo.comMithra prices private placement to raise EUR 20 million in equityAugust 24, 2023 | finance.yahoo.com Get Mithra Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MITPF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MITPF Media Mentions By Week MITPF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MITPF News Sentiment▼0.000.53▲Average Medical News Sentiment MITPF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MITPF Articles This Week▼00▲MITPF Articles Average Week Get the Latest News and Ratings for MITPF and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Mithra Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies TGIFF News Today FFNTF News Today ABSCF News Today LBTSF News Today AZFL News Today ERBB News Today AVTBF News Today AVCNF News Today BIOYF News Today CBGL News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:MITPF) was last updated on 10/4/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingThe warning signs that preceded the 2008 crash are reappearing: an irrational NASDAQ bubble, a record-high gol...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTilson: “I’m watching HOOD”A strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...Stansberry Research | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredU.S. Government Sparking Crypto RallySecond Chances Don't Come Often in Crypto My "Crypto Bull Run Millionaire Blueprint" reveals everything - w...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mithra Pharmaceuticals SA Please log in to your account or sign up in order to add this asset to your watchlist. Share Mithra Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
